Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40012301
Localisation
Germany
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
16/01/2025
Statut
Classification
1.5°C
Année cible
FY2029
Near-Term Targets: Rentschler Biopharma SE commits to reduce absolute scope 1 and 2 GHG emissions 37.8% by FY2029 from a FY2023 base year. Rentschler Biopharma SE also commits that 81.8% of its suppliers by emissions covering purchased goods and services, will have science-based targets by FY2029.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques